MoonLake Immunotherapeutics's total assets for Q4 2023 were $526.54M, an increase of 5.26% from the previous quarter. MLTX total liabilities were $13.05M for the fiscal quarter, a 23.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.